US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeOnc Technologies Holdings

6.32

-0.6300-9.06%

Post-market: 6.320.00000.00%16:05 EDT

Volume:47.69K

Turnover:316.68K

Market Cap:118.47M

PE:-9.16

High:7.00

Open:6.53

Low:5.86

Close:6.95

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

NeOnc Technologies announces global patent portfolio totals 176

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets

NeOnc Technologies Expects Full Enrollment in Phase 2a Trialfor NEO100-01 by September

MT Newswires Live

BRIEF-Neonc Technologies Holdings Expects Full Enrollment In Promising Phase 2A Trial Of Neo100-01 For Malignant Gliomas In September

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NTHI"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTHI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTHI\",,,,,undefined,":{"symbol":"NTHI","market":"US","secType":"STK","nameCN":"NeOnc Technologies Holdings","latestPrice":6.32,"timestamp":1745265600000,"preClose":6.95,"halted":0,"volume":47685,"hourTrading":{"tag":"盘后","latestPrice":6.32,"preClose":6.32,"latestTime":"16:05 EDT","volume":2,"amount":12.86,"timestamp":1745265912201},"delay":0,"floatShares":5219711,"shares":18745865,"eps":-0.69,"marketStatus":"Not Yet Opened","change":-0.63,"latestTime":"04-21 16:00:00 EDT","open":6.53,"high":7,"low":5.86,"amount":316677.5615,"amplitude":0.164029,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.69,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":0,"listingDate":1711512000000,"exchange":"NASDAQ","adjPreClose":6.95,"preHourTrading":{"tag":"盘前","latestPrice":6.66,"preClose":6.95,"latestTime":"08:57 EDT","volume":70,"amount":466.2,"timestamp":1745240240301},"postHourTrading":{"tag":"盘后","latestPrice":6.32,"preClose":6.32,"latestTime":"16:05 EDT","volume":2,"amount":12.86,"timestamp":1745265912201},"volumeRatio":0.900342},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTHI\",,,,,undefined,":{"symbol":"NTHI","floatShares":5219711,"roa":"-189.56%","roe":"--","lyrEps":-0.686076,"volumeRatio":0.900342,"shares":18745865,"dividePrice":0,"high":7,"amplitude":0.164029,"preClose":6.95,"low":5.86,"week52Low":5.86,"pbRate":"-21.52","psRate":"1427.40","week52High":25,"institutionHeld":0,"latestPrice":6.32,"eps":-0.69,"divideRate":0,"volume":47685,"delay":0,"ttmEps":-0.69,"open":6.53,"prevYearClose":25,"prevWeekClose":6.95,"prevMonthClose":13.36,"prevQuarterClose":13.36,"fiveDayClose":9.04},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NTHI\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NTHI\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527415751","title":"NeOnc Technologies announces global patent portfolio totals 176","url":"https://stock-news.laohu8.com/highlight/detail?id=2527415751","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527415751?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:35","pubTimestamp":1744720548,"startTime":"0","endTime":"0","summary":"NeOnc Technologies (NTHI) announced that its global patent portfolio totals 176, reinforcing its competitive position. The Company’s IP portfolio, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neonc-technologies-announces-global-patent-portfolio-totals-176?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neonc-technologies-announces-global-patent-portfolio-totals-176?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NTHI","BK4007"],"gpt_icon":0},{"id":"2527418493","title":"NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2527418493","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527418493?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:05","pubTimestamp":1744718700,"startTime":"0","endTime":"0","summary":"-- 176 Patents Issued and Outstanding Reinforces NeOnc’s Competitive Position -- CALABASAS, Calif., April  15, 2025  (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a biopharmace","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/15/3061691/0/en/NeOnc-Technologies-Global-Patent-Portfolio-Covers-Core-Pipeline-Across-All-Major-Pharmaceutical-Markets.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"gpt_icon":0},{"id":"2527194992","title":"NeOnc Technologies Expects Full Enrollment in Phase 2a Trialfor NEO100-01 by September","url":"https://stock-news.laohu8.com/highlight/detail?id=2527194992","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527194992?lang=en_us&edition=fundamental","pubTime":"2025-04-14 23:34","pubTimestamp":1744644866,"startTime":"0","endTime":"0","summary":"NeOnc Technologies  said Monday it expects full enrollment in a phase 2a trial for its therapeutic candidate NEO100-01 by September, with just six patients remaining to reach the 25-patient target.The trial is evaluating NEO100, which is intended for the treatment of malignant gliomas, particularly IDH1 mutant Grade III and IV astrocytomas. The read-out for the trial's data is expected early next year, the company said.The drug candidate has been granted orphan drug and fast-track status by the US Food and Drug Administration, according to the company.Price: 8.64, Change: -0.27, Percent Change: -3.03","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NTHI","BK4007"],"gpt_icon":0},{"id":"2527608591","title":"BRIEF-Neonc Technologies Holdings Expects Full Enrollment In Promising Phase 2A Trial Of Neo100-01 For Malignant Gliomas In September","url":"https://stock-news.laohu8.com/highlight/detail?id=2527608591","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527608591?lang=en_us&edition=fundamental","pubTime":"2025-04-14 22:10","pubTimestamp":1744639839,"startTime":"0","endTime":"0","summary":"BRIEF-Neonc Technologies Holdings Expects Full EnrollmentIn Promising Phase 2A Trial Of Neo100-01 For Malignant GliomasIn SeptemberApril 14 (Reuters) - Neonc Technologies Holdings Inc NTHI.O:NEONC TEC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nTUA30XSJQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTHI\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTHI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NTHI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NTHI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NTHI","date":"2025-04-17","current":-11.028403,"percent":0.9375,"low":-26.074295,"twenty":-19.044476,"median":-15.392499,"eighty":-12.855967,"high":-11.028403,"avg":-16.351317,"sd":3.867449,"marketCap":131221055},"quantilePoints":[{"date":"2024-03-28","current":-18.899455,"twenty":-18.899455,"median":-18.899455,"eighty":-18.899455,"marketCap":282000000},{"date":"2025-03-28","current":-18.905834,"twenty":-19.009816,"median":-18.905834,"eighty":-18.902007,"marketCap":224950380},{"date":"2025-04-04","current":-15.093157,"twenty":-20.260752,"median":-18.902645,"eighty":-16.151884,"marketCap":179585386},{"date":"2025-04-11","current":-14.179375,"twenty":-19.504518,"median":-17.739974,"eighty":-15.124667,"marketCap":168712785},{"date":"2025-04-17","current":-11.028403,"twenty":-19.044476,"median":-15.392499,"eighty":-12.855967,"marketCap":131221055}],"updateTime":1745285727922}}}